Print version of this report
TGA Action ID RC-2024-RN-00960-1
Type of Product Medicine
Product Name/Description Hepatitis B Immunoglobulin-VF 100IU AU

Batch Number: 3640800146

Expiry Date: 12-Oct-2026

ARTG 61213
ARTG Number 61213
Action Type Product Defect Alert
Action Level Hospital
Hazard Classification Class II
Reason for the Action Batch contains incorrect fill volume printed on the packaging materials.

A printing error has been identified on the product carton and vial label of Hepatitis B Immunoglobulin-VF 100IU, batch 3640800146, expiry date 12-Oct-2026.

The carton and vial state that the volume of product contained in the vial is 0.43mL, however, the carton and vial label should state 1.00mL as this is volume within the vial.
Instructions for Customers/Users Product Defect Alert
· CSL Behring can confirm that this batch can continue to be prescribed and administered in accordance with the Hepatitis B Immunoglobulin – VF PI which can be found at https://labeling.cslbehring.com/PI/AU/Hepatitis-B-Immunoglobulin-P/EN/Hepatitis-B-Immunoglobulin-VF-Product-Information.pdf. If you receive this batch, please ensure you administer the full contents of the vial (1mL) to receive the required dose.
· If two vials (2mL) of the impacted 100IU vial was dosed as a result of the labelling error, review the patient as required.

Warehouse Product Defect Correction
· For warehouses only, the stock currently in the 3PL distribution centres, including National Reserve will be returned to CSL Behring for correction.

This action has been finalised on 12/2/2025.
Action Commencement Date 31/10/2024
Responsible Entity CSL Behring Australia Pty Ltd
Contact Information 1800 642 865 - Medical Information team